Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection
YZ Cohen, M Caskey - Current Opinion in HIV and AIDS, 2018 - journals.lww.com
YZ Cohen, M Caskey
Current Opinion in HIV and AIDS, 2018•journals.lww.comSummary bNAbs may offer advantages over traditional ART for both the prevention and
treatment of HIV-1 infection. In addition, bNAbs may target the latent viral reservoir. bNAb
combinations and bNAbs engineered for prolonged half-life and increased potency are
currently undergoing clinical evaluation.
treatment of HIV-1 infection. In addition, bNAbs may target the latent viral reservoir. bNAb
combinations and bNAbs engineered for prolonged half-life and increased potency are
currently undergoing clinical evaluation.
Summary
bNAbs may offer advantages over traditional ART for both the prevention and treatment of HIV-1 infection. In addition, bNAbs may target the latent viral reservoir. bNAb combinations and bNAbs engineered for prolonged half-life and increased potency are currently undergoing clinical evaluation.
Lippincott Williams & Wilkins